Is a complete DSE/PHARMAID research report available?

No complete published report is available for dse/PHARMAID (DSE/PHARMAID) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/PHARMAID (DSE/PHARMAID)

Dhaka Stock Exchange: DSE/PHARMAID · BDT

BDT 545

-1.50 (-0.3%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	495.7M
Net income (ttm)	77.6M
EPS (ttm)	BDT 24.9
Shares out	3.1M
P/E (trailing)	21.9x
Dividend	BDT 3.00 (0.55%)
Volume	5,004
Beta	0.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 495.7M
Net income (ttm): 77.6M
EPS (ttm): BDT 24.9
P/E (trailing): 21.9x
Market cap: 1.7B

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-04
Employees	94
Employees change	8
Employees growth	9.3%
Enterprise value	BDT 1.7B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1981
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0462PHAID7
Last earnings date	2026-04-29
Last refreshed	2026-10-29
Last stock split date	2011-12-04
Last stock split type	Forward
Market cap	BDT 1.7B
Next earnings date	2026-11-04
Price	BDT 544.60
Price currency	BDT
SIC code	2834
Stock price date	2026-10-29
Symbol	dse/PHARMAID
Website	https://www.pharmaaids.com

Metric

Value

Amount currency

BDT

Country

Bangladesh

Country code

Earnings date

2026-11-04

Employees

Employees change

Employees growth

9.3%

Enterprise value

BDT 1.7B

Exchange

Dhaka Stock Exchange

Financial currency

BDT

Financial report date

2026-03-31

First seen

2026-05-10

Fiscal year end

June

Founded

1981

Industry

Pharmaceutical Preparations

Is primary listing

Yes

ISIN number

BD0462PHAID7

Last earnings date

2026-04-29

Last refreshed

2026-10-29

Last stock split date

2011-12-04

Last stock split type

Forward

Market cap

BDT 1.7B

Next earnings date

2026-11-04

Price

BDT 544.60

Price currency

BDT

SIC code

2834

Stock price date

2026-10-29

Symbol

dse/PHARMAID

Website

https://www.pharmaaids.com

Metric	Value
Average P/E ratio (10Y)	47.9x
Average P/E ratio (3Y)	36.34x
Average P/E ratio (5Y)	67.28x
Earnings yield	4.57%
EV/Earnings	21.66x
EV/EBIT	16.16x
EV/EBITDA	14.81x
EV/FCF	249.66x
EV/Sales	3.39x
FCF / EV yield	0.4%
FCF yield	0.4%
Graham number	295.13053
Graham upside	-45.96%
Industry P/E	9.79x
Lynch fair value	BDT 276.95
Lynch upside	-49.29%
P/B ratio	3.51x
P/E ratio	21.88x
P/FCF ratio	252.91x
P/OCF ratio	27.08x
P/S ratio	3.44x
Price / tangible book value	3.51x
Price/EBITDA ratio	15x

Metric

Value

Average P/E ratio (10Y)

47.9x

Average P/E ratio (3Y)

36.34x

Average P/E ratio (5Y)

67.28x

Earnings yield

4.57%

EV/Earnings

21.66x

EV/EBIT

16.16x

EV/EBITDA

14.81x

EV/FCF

249.66x

EV/Sales

3.39x

FCF / EV yield

0.4%

FCF yield

0.4%

Graham number

295.13053

Graham upside

-45.96%

Industry P/E

9.79x

Lynch fair value

BDT 276.95

Lynch upside

-49.29%

P/B ratio

3.51x

P/E ratio

21.88x

P/FCF ratio

252.91x

P/OCF ratio

27.08x

P/S ratio

3.44x

Price / tangible book value

3.51x

Price/EBITDA ratio

15x

Metric	Value
EBIT margin	21%
EBITDA margin	22.92%
Effective tax rate	23.7%
FCF margin	1.36%
Gross margin	31.4%
Operating margin	21%
Pretax margin	20.53%
Profit margin	15.66%
Profit per employee	BDT 826,020
Revenue per employee	BDT 5.3M
ROA	10.57%
ROA (5Y)	9.15%
ROCE	21.3%
ROE	17.19%
ROE (5Y)	12.75%
ROIC	17.52%
ROIC (5Y)	13.32%
Tax / revenue	4.87%

Metric

Value

EBIT margin

21%

EBITDA margin

22.92%

Effective tax rate

23.7%

FCF margin

1.36%

Gross margin

31.4%

Operating margin

21%

Pretax margin

20.53%

Profit margin

15.66%

Profit per employee

BDT 826,020

Revenue per employee

BDT 5.3M

ROA

10.57%

ROA (5Y)

9.15%

ROCE

21.3%

ROE

17.19%

ROE (5Y)

12.75%

ROIC

17.52%

ROIC (5Y)

13.32%

Tax / revenue

4.87%

Metric	Value
EPS growth	46.27%
EPS growth (Q)	37.32%
EPS growth (QoQ)	-16%
EPS growth 10Y	13.1%
EPS growth 5Y	11.13%
FCF growth (Q)	624.4%
FCF growth (QoQ)	130.23%
FCF growth 5Y	-22.6%
Gross profit growth	28.95%
Gross profit growth (Q)	29.69%
Gross profit growth 3Y	44.71%
Gross profit growth 5Y	9.48%
Net income growth	46.27%
Net income growth (Q)	37.32%
Net income growth (QoQ)	-16%
Net income growth 5Y	11.13%
OCF growth	27,438.32%
OCF growth (Q)	340.08%
OCF growth (QoQ)	133.16%
OCF growth 10Y	78.92%
OCF growth 3Y	172.47%
OCF growth 5Y	12.75%
Operating income growth	39.87%
Operating income growth (Q)	42.68%
Operating income growth 3Y	474.51%
Operating income growth 5Y	10.94%
Revenue growth	18.93%
Revenue growth (Q)	20.79%
Revenue growth (QoQ)	-13.37%
Revenue growth 10Y	13.56%
Revenue growth 3Y	17.99%
Revenue growth 5Y	12.78%

Metric

Value

EPS growth

46.27%

EPS growth (Q)

37.32%

EPS growth (QoQ)

-16%

EPS growth 10Y

13.1%

EPS growth 5Y

11.13%

FCF growth (Q)

624.4%

FCF growth (QoQ)

130.23%

FCF growth 5Y

-22.6%

Gross profit growth

28.95%

Gross profit growth (Q)

29.69%

Gross profit growth 3Y

44.71%

Gross profit growth 5Y

9.48%

Net income growth

46.27%

Net income growth (Q)

37.32%

Net income growth (QoQ)

-16%

Net income growth 5Y

11.13%

OCF growth

27,438.32%

OCF growth (Q)

340.08%

OCF growth (QoQ)

133.16%

OCF growth 10Y

78.92%

OCF growth 3Y

172.47%

OCF growth 5Y

12.75%

Operating income growth

39.87%

Operating income growth (Q)

42.68%

Operating income growth 3Y

474.51%

Operating income growth 5Y

10.94%

Revenue growth

18.93%

Revenue growth (Q)

20.79%

Revenue growth (QoQ)

-13.37%

Revenue growth 10Y

13.56%

Revenue growth 3Y

17.99%

Revenue growth 5Y

12.78%

Metric	Value
Capital expenditures	BDT -56.2M
Depreciation and amortization	BDT 9.5M
EBIT	BDT 104.1M
EBITDA	BDT 113.6M
EPS	BDT 24.89
FCF per share	BDT 2.16
Financing cash flow	BDT -10M
Free cash flow	BDT 6.7M
Gross profit	BDT 155.7M
Income taxes	BDT 24.1M
Investing cash flow	BDT -56.7M
Net borrowing	BDT -325,993
Net cash flow	BDT -3.8M
Net income	BDT 77.6M
Operating income	BDT 104.1M
Revenue	BDT 495.7M

Metric

Value

Capital expenditures

BDT -56.2M

Depreciation and amortization

BDT 9.5M

EBIT

BDT 104.1M

EBITDA

BDT 113.6M

EPS

BDT 24.89

FCF per share

BDT 2.16

Financing cash flow

BDT -10M

Free cash flow

BDT 6.7M

Gross profit

BDT 155.7M

Income taxes

BDT 24.1M

Investing cash flow

BDT -56.7M

Net borrowing

BDT -325,993

Net cash flow

BDT -3.8M

Net income

BDT 77.6M

Operating income

BDT 104.1M

Revenue

BDT 495.7M

Metric	Value
Altman Z-Score	9.17
Book value per share	BDT 155.55
Debt / EBITDA	0.15
Debt / equity	0.04
Debt / FCF	2.56
Interest coverage	42.65
Long-term assets	BDT 140.3M
Long-term liabilities	BDT 3.4M
Net cash (debt)	BDT 21.9M
Net cash / market cap	1.28%
Net cash growth	10.72%
Net debt / EBITDA	-0.19
Net debt / equity	-0.05
Net debt / FCF	-3.25
Piotroski F-Score	6
Property, plant and equipment	BDT 140.3M
Shareholders' equity	BDT 485.3M
Tangible book value	BDT 485.3M
Tangible book value per share	BDT 155.55
Total assets	BDT 647.2M
Total cash	BDT 39.2M
Total debt	BDT 17.3M
Total liabilities	BDT 161.9M
WACC	5.3%

Metric

Value

Altman Z-Score

9.17

Book value per share

BDT 155.55

Debt / EBITDA

0.15

Debt / equity

0.04

Debt / FCF

2.56

Interest coverage

42.65

Long-term assets

BDT 140.3M

Long-term liabilities

BDT 3.4M

Net cash (debt)

BDT 21.9M

Net cash / market cap

1.28%

Net cash growth

10.72%

Net debt / EBITDA

-0.19

Net debt / equity

-0.05

Net debt / FCF

-3.25

Piotroski F-Score

Property, plant and equipment

BDT 140.3M

Shareholders' equity

BDT 485.3M

Tangible book value

BDT 485.3M

Tangible book value per share

BDT 155.55

Total assets

BDT 647.2M

Total cash

BDT 39.2M

Total debt

BDT 17.3M

Total liabilities

BDT 161.9M

WACC

5.3%

Metric	Value
Asset turnover	0.81
Current assets	BDT 506.9M
Current liabilities	BDT 158.5M
Current ratio	3.2
Inventory turnover	4.73
Net working capital	BDT 326.6M
Quick ratio	1.47
Working capital	BDT 348.5M
Working capital turnover	1.47

Metric

Value

Asset turnover

0.81

Current assets

BDT 506.9M

Current liabilities

BDT 158.5M

Current ratio

3.2

Inventory turnover

4.73

Net working capital

BDT 326.6M

Quick ratio

1.47

Working capital

BDT 348.5M

Working capital turnover

1.47

Metric	Value
Dividend growth	20%
Dividend growth (10Y)	1.84%
Dividend growth (3Y)	-15.66%
Dividend growth (5Y)	-9.71%
Dividend growth years	2
Dividend payment date	2026-01-25
Dividend payment years	18
Dividend payout frequency	Annual
Dividend per share	BDT 3.00
Dividend yield	0.55%
Ex-dividend date	2025-12-08
FCF payout ratio	138.94%
Last dividend	BDT 3.00
Payout ratio	12.49%
Shareholder yield	0.55%

Metric

Value

Dividend growth

20%

Dividend growth (10Y)

1.84%

Dividend growth (3Y)

-15.66%

Dividend growth (5Y)

-9.71%

Dividend growth years

Dividend payment date

2026-01-25

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

BDT 3.00

Dividend yield

0.55%

Ex-dividend date

2025-12-08

FCF payout ratio

138.94%

Last dividend

BDT 3.00

Payout ratio

12.49%

Shareholder yield

0.55%

Metric	Value
10Y price change	115.77%
10Y return CAGR	8.86%
10Y total return	133.59%
150-day SMA	BDT 571.57
15Y price change	205%
15Y return CAGR	8.62%
15Y total return	245.84%
1D price change	-0.27%
1M price change	-1.76%
1M total return	-1.76%
1W price change	1.7%
1W total return	1.7%
1Y price change	6.58%
1Y return CAGR	7.2%
1Y total return	7.2%
20-day SMA	BDT 552.56
200-day SMA	BDT 560.89
20Y price change	5,397.84%
20Y return CAGR	23.42%
20Y total return	6,619.54%
3M price change	-11.35%
3M total return	-11.35%
3Y price change	-30.93%
3Y return CAGR	-11.27%
3Y total return	-30.15%
50-day SMA	BDT 563.08
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 680.00
52-week high date	2026-07-16
52-week low	BDT 452.70
52-week low date	2025-11-13
5Y price change	4.36%
5Y return CAGR	1.41%
5Y total return	7.25%
6M price change	-0.38%
6M total return	-0.38%
All-time high	BDT 980.00
All-time high date	2022-08-28
All-time low	BDT 0.70
All-time low date	1997-06-09
Average true range (ATR)	BDT 15.30
Average volume	9.3K
Beta (1Y)	-0.26
Beta (2Y)	-0.24
Beta (5Y)	0.18
Change from 52-week high	-19.91%
Change from 52-week low	20.3%
Change from all-time high	-44.28%
Change from all-time low	77,958.89%
Dollar volume	BDT 2.7M
High price	BDT 547.20
Low price	BDT 540.00
Monthly RSI	45.08
Position in 52-week range	63.89%
Previous close	BDT 546.10
Price vs 150-day SMA	-4.46%
Price vs 20-day SMA	-1.17%
Price vs 200-day SMA	-2.64%
Price vs 50-day SMA	-3.01%
Relative volume	0.54
RSI	45.07
Sharpe ratio	-0.22
Sharpe ratio (3Y)	-0.34
Sharpe ratio (5Y)	0.24
Sortino ratio	-0.14
Sortino ratio (3Y)	-0.33
Sortino ratio (5Y)	0.57
Volume	5K
Weekly RSI	99.93
YTD price change	12.81%
YTD total return	12.81%

Metric

Value

10Y price change

115.77%

10Y return CAGR

8.86%

10Y total return

133.59%

150-day SMA

BDT 571.57

15Y price change

205%

15Y return CAGR

8.62%

15Y total return

245.84%

1D price change

-0.27%

1M price change

-1.76%

1M total return

-1.76%

1W price change

1.7%

1W total return

1.7%

1Y price change

6.58%

1Y return CAGR

7.2%

1Y total return

7.2%

20-day SMA

BDT 552.56

200-day SMA

BDT 560.89

20Y price change

5,397.84%

20Y return CAGR

23.42%

20Y total return

6,619.54%

3M price change

-11.35%

3M total return

-11.35%

3Y price change

-30.93%

3Y return CAGR

-11.27%

3Y total return

-30.15%

50-day SMA

BDT 563.08

50-day SMA vs 200-day SMA

50over200

52-week high

BDT 680.00

52-week high date

2026-07-16

52-week low

BDT 452.70

52-week low date

2025-11-13

5Y price change

4.36%

5Y return CAGR

1.41%

5Y total return

7.25%

6M price change

-0.38%

6M total return

-0.38%

All-time high

BDT 980.00

All-time high date

2022-08-28

All-time low

BDT 0.70

All-time low date

1997-06-09

Average true range (ATR)

BDT 15.30

Average volume

9.3K

Beta (1Y)

-0.26

Beta (2Y)

-0.24

Beta (5Y)

0.18

Change from 52-week high

-19.91%

Change from 52-week low

20.3%

Change from all-time high

-44.28%

Change from all-time low

77,958.89%

Dollar volume

BDT 2.7M

High price

BDT 547.20

Low price

BDT 540.00

Monthly RSI

45.08

Position in 52-week range

63.89%

Previous close

BDT 546.10

Price vs 150-day SMA

-4.46%

Price vs 20-day SMA

-1.17%

Price vs 200-day SMA

-2.64%

Price vs 50-day SMA

-3.01%

Relative volume

0.54

RSI

45.07

Sharpe ratio

-0.22

Sharpe ratio (3Y)

-0.34

Sharpe ratio (5Y)

0.24

Sortino ratio

-0.14

Sortino ratio (3Y)

-0.33

Sortino ratio (5Y)

0.57

Volume

Weekly RSI

99.93

YTD price change

12.81%

YTD total return

12.81%

Metric	Value
Float	2.5M
Shares change (QoQ)	0%
Shares held by insiders	18.78%
Shares outstanding	3.1M

Metric

Value

Float

2.5M

Shares change (QoQ)

Shares held by insiders

18.78%

Shares outstanding

3.1M

DSE/PHARMAID (DSE/PHARMAID)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/PHARMAID

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/PHARMAID indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/PHARMAID

Frequently asked questions